Expert Rev Cardiovasc Ther. 2009 Feb;7(2):131-8.

Prevalence of anemia in heart failure and its effects on prognosis.

Source

Head of Heart Failure Unit, Cardiology Department, Hospital Italiano de Buenos Aires, Gascón 450, Ciudad de Buenos Aires (1181), Argentina. cesar.belziti@hospitalitaliano.org.ar

Abstract

Anemia is common in heart failure patients but its prevalence varies widely according to various sources. There is no agreement regarding the definition of anemia to be used and several risk factors have been found to be associated with higher prevalence of anemia in heart failure patients. The prevalence of anemia depends on its definition and the clinical characteristics of the patients included in the studies. Anemia is associated with adverse prognosis in the general population, in patients with end-stage renal disease, chronic diseases, coronary artery disease and also in patients with heart failure; however, despite all the information available, the issue of whether anemia is an independent predictor of mortality and the nature of the risk between anemia and mortality in heart failure patients are not yet fully understood.

PMID:: 19210209; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

Hemoglobins

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. [Am J Cardiol. 2003]
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.
Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM. Am J Cardiol. 2003 Sep 1; 92(5):625-8.
Review The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes. [Heart Fail Rev. 2008]
Review The prevalence of anemia in chronic heart failure and its impact on the clinical outcomes.
Tang YD, Katz SD. Heart Fail Rev. 2008 Dec; 13(4):387-92. Epub 2008 Feb 2.
Review Prevalence of anemia and effects on mortality in patients with heart failure. [Am Heart J. 2005]
Review Prevalence of anemia and effects on mortality in patients with heart failure.
Lindenfeld J. Am Heart J. 2005 Mar; 149(3):391-401.
Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. [J Am Coll Cardiol. 2008]
Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.
Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB. J Am Coll Cardiol. 2008 Feb 5; 51(5):569-76.
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. [Circulation. 2006]
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Lang CC, Roger SD, Young JB, Solomon SD, Granger CB, Ostergren J, et al. Circulation. 2006 Feb 21; 113(7):986-94. Epub 2006 Feb 13.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Prevalence of anemia in heart failure and its effects on prognosis.
Prevalence of anemia in heart failure and its effects on prognosis.
Expert Rev Cardiovasc Ther. 2009 Feb ;7(2):131-8.

PubMed
Effects of 32-year leisure time physical activity discordance in twin pairs on h...
Effects of 32-year leisure time physical activity discordance in twin pairs on health (TWINACTIVE study): aims, design and results for physical fitness.
Twin Res Hum Genet. 2009 Feb ;12(1):108-17.

PubMed
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in he...
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.
J Infect Dis. 2009 Mar 1 ;199(5):711-6.

PubMed
Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Escitalopram in the treatment of major depressive disorder: a meta-analysis.
Curr Med Res Opin. 2009 Jan ;25(1):161-75.

PubMed
Limitations of statin monotherapy for the treatment of dyslipidemia: a projectio...
Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study--observational.
Curr Med Res Opin. 2009 Jan ;25(1):47-55.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: